Back

Prognostic impact of symptom relief under low and normal physical performance in patients hospitalized for worsening heart failure

31 August 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Added value of stress tests in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yu Yamada

Yokohama City University Hospital, Yokohama (Japan)

7 More presentations in this session

Presentation thumbnail
Assessment of cardiopulmonary exercise capacity in suspected heart failure with preserved ejection fraction: impact of coronary flow velocity reserve and body fat
Doctor S. Kim (Seoul, KR) Professor S. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Beyond resting measurements: exercise pulse pressure and its association with heart failure hospitalization
Doctor Y. Fu (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
O2 consumption overshoot in patients with heart failure: crossing the line.
Doctor R. Carvalho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Exercise stress testing recovery kinetics: the forgotten phase.
Doctor R. Carvalho (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of peak heart rate on cardiopulmonary exercise testing in patients with chronic heart failure
Doctor Y. Shimono (Sapporo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Added value of stress tests in heart failure

The Event

Event poster

ESC Congress 2024

31 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of residual symptoms at discharge in patients hospitalized for worsening heart failure
thumbnail
Congress Presentation
Prognostic impact of patterns of in-hospital heart failure on clinical outcomes after myocardial infarction
thumbnail
Congress Presentation
Prognostic impact of multimorbidity and frailty on 90-day survival in older patients hospitalised for acute heart failure: a prospective study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources